• Ilan Goldenberg, Samuel Horr, Arthur J Moss, Coeli M Lopes, Alon Barsheshet, Scott McNitt, Wojciech Zareba, Mark L Andrews, Jennifer L Robinson, Emanuela H Locati, Michael J Ackerman, Jesaia Benhorin, Elizabeth S Kaufman, Carlo Napolitano, Pyotr G Platonov, Silvia G Priori, Ming Qi, Peter J Schwartz, Wataru Shimizu, Jeffrey A Towbin, G Michael Vincent, Arthur A M Wilde, and Li Zhang.
• Cardiology Division of Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA. ilan.goldenberg@heart.rochester.edu
• J. Am. Coll. Cardiol. 2011 Jan 4; 57 (1): 51-9.

ObjectivesThis study was designed to assess the clinical course and to identify risk factors for life-threatening events in patients with long-QT syndrome (LQTS) with normal corrected QT (QTc) intervals.BackgroundCurrent data regarding the outcome of patients with concealed LQTS are limited.MethodsClinical and genetic risk factors for aborted cardiac arrest (ACA) or sudden cardiac death (SCD) from birth through age 40 years were examined in 3,386 genotyped subjects from 7 multinational LQTS registries, categorized as LQTS with normal-range QTc (≤ 440 ms [n = 469]), LQTS with prolonged QTc interval (> 440 ms [n = 1,392]), and unaffected family members (genotyped negative with ≤ 440 ms [n = 1,525]).ResultsThe cumulative probability of ACA or SCD in patients with LQTS with normal-range QTc intervals (4%) was significantly lower than in those with prolonged QTc intervals (15%) (p < 0.001) but higher than in unaffected family members (0.4%) (p < 0.001). Risk factors ACA or SCD in patients with normal-range QTc intervals included mutation characteristics (transmembrane-missense vs. nontransmembrane or nonmissense mutations: hazard ratio: 6.32; p = 0.006) and the LQTS genotypes (LQTS type 1:LQTS type 2, hazard ratio: 9.88; p = 0.03; LQTS type 3:LQTS type 2, hazard ratio: 8.04; p = 0.07), whereas clinical factors, including sex and QTc duration, were associated with a significant increase in the risk for ACA or SCD only in patients with prolonged QTc intervals (female age > 13 years, hazard ratio: 1.90; p = 0.002; QTc duration, 8% risk increase per 10-ms increment; p = 0.002).ConclusionsGenotype-confirmed patients with concealed LQTS make up about 25% of the at-risk LQTS population. Genetic data, including information regarding mutation characteristics and the LQTS genotype, identify increased risk for ACA or SCD in this overall lower risk LQTS subgroup.Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

26 keywords...

hide…